J Eval Clin Pract. 2026 Oct;32(7):e70674. doi: 10.1111/jep.70674.
ABSTRACT
RATIONALE, AIMS AND OBJECTIVES: A validated rule-out instrument can turn the collective absence of warning findings into an explicit warrant for stopping a specified diagnostic inquiry. This paper characterises that inversion in clinical use and asks whether 'red flag' adequately distinguishes it from using positive signs to pursue suspected lesions.
METHOD: Comparative conceptual analysis of the clinical sign, exemplified by Babinski's plantar response, and the Ottawa Subarachnoid Hemorrhage Rule. The Clinical Standards Advisory Group (CSAG) back-pain guidance and SNNOOP10 headache checklist are examined as heterogeneous comparators. Five objections test the argument, including its compatibility with Bayesian reasoning.
RESULTS: The inversion concerns intended clinical use and the direction of licensed action, rather than an intrinsic direction of inference determined by sensitivity or specificity. Ottawa provides the paradigm case: within its defined eligible population, absence of all criteria can support foregoing further investigation for subarachnoid haemorrhage. A positive result does not establish the diagnosis, and the composite rule's low specificity does not make every constituent criterion uninformative. Three consequences follow: licensed action can shift from pursuit to stopping; epistemic authority is partly redistributed toward validated thresholds; and negative findings can provide a shared justification for closing a specified diagnostic pathway. Clinical judgement remains necessary throughout. Resource consequences should be distinguished from rationing.
CONCLUSIONS: The distinctive object is a decision architecture connecting evidence to permission not to investigate. Its limits become clearer when validated rule-out instruments are distinguished from mixed warning checklists and their practical function is separated from their probabilistic properties.
PMID:42862942 | DOI:10.1111/jep.70674